Adult & Pediatric Allergy & Immunology Salary Guide 2026: Complete Earnings Analysis

Understanding the PAAI Credential

Before discussing earnings potential, it's worth being precise about what this certification actually is. The Certification in Adult & Pediatric Allergy & Immunology Subspecialty is administered by the American Osteopathic Conjoint Examination Committee on Pediatric and Adult Allergy and Immunology, operating under the American Osteopathic Association. The exam program itself is referred to as PAAI. This is not a generic allergy credential - it sits specifically within the osteopathic certification pathway, requiring candidates to already hold AOBIM or AOBP primary certification before they're eligible to sit for the subspecialty exam.

That eligibility structure matters for anyone thinking about salary and career trajectory. Because PAAI certification is layered on top of an existing osteopathic internal medicine or pediatric board certification, physicians pursuing it are already established in a primary specialty. The subspecialty credential functions as an additional, specialized qualification rather than a standalone entry point into medicine. If you're still mapping out what the credential covers before worrying about compensation, the overview of what this certification represents is a useful starting point.

What Actually Drives Earnings for Certified Physicians

There's no published, verifiable salary dataset specific to PAAI-certified physicians that we can responsibly cite here, and this guide won't manufacture numbers to fill that gap. What can be said with confidence is that earnings for allergy/immunology subspecialists - osteopathic or allopathic - are shaped by a consistent set of variables:

• Practice setting: academic medical centers, private allergy/immunology groups, hospital-employed positions, and multi-specialty clinics each structure compensation differently.
• Geographic market: regional demand for allergy/immunology subspecialists varies significantly, and underserved areas often carry different compensation dynamics than saturated metro markets.
• Scope of practice: whether a physician treats both adult and pediatric populations (as this dual-population certification supports) versus a narrower focus.
• Years in subspecialty practice: experience and patient panel size compound over time regardless of credential.
• Primary board pathway: since PAAI requires AOBIM or AOBP certification first, a physician's primary specialty track also shapes career and compensation trajectory before the subspecialty is even added.

Rather than quoting speculative figures, the more useful exercise is understanding how the certification itself is structured, because that structure - content weighting, eligibility rules, renewal terms - is what actually differentiates PAAI-certified physicians in hiring conversations.

Who Hires Osteopathic Allergy/Immunology Physicians

Physicians who complete PAAI certification typically pursue roles across several settings:

• Osteopathic and allopathic hospital systems building out allergy/immunology service lines for both adult and pediatric patients.
• Private allergy/immunology practice groups seeking subspecialists who can manage a combined adult-pediatric patient population.
• Academic osteopathic medical centers involved in fellowship training, where subspecialty board certification is often a baseline expectation.
• Multi-specialty clinics that need in-house allergy/immunology expertise rather than referring out.

Because the credential explicitly covers both adult and pediatric populations, certified physicians can position themselves for roles that would otherwise require separate adult-only or pediatric-only subspecialists. That dual scope is a structural feature of the certification itself, not a marketing claim - it's baked into the eligibility requirement of qualifying allergy/immunology fellowship training verified for both populations. For more on how the field itself is defined, see this explainer on what the credential means and the related piece on career paths and job types in this subspecialty.

The Certification Investment vs. Long-Term Value

Every certification carries a cost, and understanding the actual fee structure helps frame the investment against a multi-year certification term. The initial PAAI examination costs $1,700. If a retake is necessary, that fee drops to $1,400. Candidates who need to withdraw can receive a refund - minus a $300 processing fee - provided the written cancellation is submitted at least 15 full days before the scheduled exam date.

Once earned, certification isn't a one-time transaction that needs annual repurchasing. The board specifies ten-year terms for certificates issued before 2025, and a two-year term specifically for the 2025 cohort. That term length matters for long-range planning: a physician certified under the ten-year structure can amortize the initial exam cost over a full decade of practice, which is a meaningfully different calculation than a credential requiring frequent re-examination.

For a full breakdown of every fee and how they interact with eligibility timing, see the certification cost breakdown, which walks through the pricing structure in more depth than is necessary here.

Why Domain Mastery Matters for Career Positioning

A physician's depth in the exam's content areas isn't just about passing - it reflects the clinical competencies employers and referring physicians expect from a certified allergy/immunology subspecialist. The exam blueprint weights eight content areas:

Understanding this weighting isn't just an exam-prep exercise - it mirrors the clinical reality of what a certified subspecialist is expected to know across a full adult-and-pediatric caseload. For a complete walkthrough of each domain and how to study for it, see the full exam domains guide. If you're still calibrating how difficult the exam actually is relative to your current knowledge base, the difficulty guide is a useful companion read.

Ongoing Costs That Factor Into Career Planning

Certification doesn't end at the exam. The Osteopathic Continuous Certification (OCC) program requires diplomates to complete 16 untimed, open-resource PAAI questions annually, with a 70% annual passing criterion, at a cost of $250 per year. The 2026 assessment cycle runs through the AOA Learning Portal. New diplomates don't start this cycle immediately - maintenance begins after one full calendar year of certification, meaning the 2025 cohort begins OCC participation in 2027.

Maintenance also folds in standard obligations: maintaining an active license, staying current on primary-board CME (with no separate conjoint-subspecialty CME quota layered on top), and completing one quality-improvement activity every ten years. None of this is burdensome relative to the exam itself, but it's a recurring line item worth budgeting for when evaluating the credential's total cost of ownership over a career.

Positioning Your Credential in Contract Negotiations

When it comes time to discuss compensation with a prospective employer or negotiate an existing contract, the specifics of this credential are more persuasive than a generic reference to "board certification." Being able to speak concretely about the eligibility bar - AOBIM or AOBP primary certification, verified fellowship training, and a passing scaled score on a 250-question exam spanning eight weighted domains - signals a level of rigor that employers evaluating allergy/immunology candidates will recognize.

It's also worth noting the senior fellow provision: candidates who have completed at least 80% of required clinical rotations may test early, though certification itself still requires verified completion of training. This detail is useful context in conversations about start dates and credentialing timelines with a future employer, since it affects when a candidate can realistically hold the credential relative to fellowship completion.

If you haven't yet mapped out your eligibility path in detail, the requirements guide lays out exactly what's needed before you can register, and understanding the passing score mechanics can help you set realistic milestones as you plan around fellowship completion and first job search.

Connecting Preparation Timeline to Career Timing

Because Basic Science alone accounts for 30% of the exam, most structured study plans front-load that domain early and revisit it repeatedly rather than treating it as one topic among eight equal ones. A sensible approach dedicates the opening weeks of a study plan to basic science fundamentals, then layers in the mid-weighted clinical domains - pulmonary diseases, upper respiratory tract disease, hypersensitivity and mast cell disorders - before finishing with the smaller-weighted areas like autoimmunity. This sequencing isn't generic study advice; it's dictated directly by how the PAAI blueprint allocates its 250 questions.

For a week-by-week breakdown built around this exact weighting, the study guide for 2026 lays out a structured timeline. Pairing that with consistent practice testing on our practice test platform lets you track readiness against the same 200-800 scaled scoring model the actual exam uses, rather than guessing at raw percentage correct.

If you're weighing whether the entire certification effort - cost, study time, exam-day logistics - is worth it relative to your career goals, the ROI analysis tackles that question directly, and reviewing current pass rate data can help set realistic expectations before you commit to a testing date. You can also use our full practice exam suite to benchmark your progress against the actual four-section, 250-question format before registration.

Frequently Asked Questions